CD274 and cholangiocarcinoma: Building on our previous finding that integrin αvβ6 expression alone was not a reliable predictor of CAR T cell activity targeting integrin αvβ6 [17], we explored the potential role of the immune checkpoint molecule PD-L1 in CCA.